Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

• Status: Completed
• Trial end date: 1990-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine if surfactant administration at birth in infants at high risk for respiratory distress syndrome (RDS) modified the clinical course of the syndrome.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Pulmonary Surfactants

Criteria

Boy and girl preterm infants 24-29 weeks of gestational age and 500-1400 grams birthweight.